Publications by authors named "J POLDERMAN"
Although sleep is essential for (recovery of) health, it is adversely affected by hospitalization, due to disease discomfort, environmental noise, and care routines, causing reduced sleep and increased disturbances. This study evaluates factors affecting sleep quality and quantity in hospitalized children and compares inpatient sleep with sleep at home. Using an observational, prospective study design, we assessed sleep in hospitalized children aged 1-12 years, admitted to a tertiary center, and compared this with home 6-8 weeks after discharge.
View Article and Find Full Text PDFIn patients born with anorectal malformations (ARM), additional congenital heart defects (CHD) can occur. We aimed to provide an overview on disease and treatment details of CHD identified in patients born with ARM, from a unique large cohort of a very rare disease. We performed a retrospective single-center cohort study between January 2000 and July 2023.
View Article and Find Full Text PDFObjective: To determine factors affecting inpatient sleep and assess the range and effectiveness of non-pharmacological interventions aimed at improving the sleep of patients admitted to regular care wards.
Methods: A systematic literature search was conducted in five scientific databases, including articles published from inception to June 23rd, 2023. Eligible studies evaluated sleep disturbing factors or the effect of non-pharmacological intervention(s).
Article Synopsis
- The PERFORM-TAVR trial aims to explore the combined effects of exercise and protein supplementation on older adults with frailty undergoing transcatheter aortic valve replacement (TAVR), which currently shows high procedural success but still leaves many patients with poor health outcomes.
- This multicentre trial will enroll 200 frail adults aged 70 and older, randomly assigning them to either standard lifestyle education (control) or a regimen involving protein-rich supplements and supervised exercises post-TAVR.
- The main goal is to measure physical performance improvements at 3 months, along with secondary outcomes like health-related quality of life and safety assessments over a year, potentially reshaping approaches to treating frailty alongside heart valve diseases.